Related Experiment Videos
Microcirculatory dynamics of neuropeptide Y
D Kim1, W R Durán, I Kobayashi
1Department of Physiology, UMDNJ-New Jersey Medical School, Newark 07103-2714.
Microvascular Research
|July 1, 1994
Summary
Neuropeptide Y (NPY) constricts arterioles in hamster cheek pouches dose-dependently. This vasoconstriction is mediated by Y1 receptors and is independent of norepinephrine, affecting microvascular hemodynamics.
Area of Science:
- Physiology
- Pharmacology
- Microcirculation Research
Background:
- Neuropeptide Y (NPY) is a peptide neurotransmitter implicated in various physiological processes.
- Its role in regulating microvascular function, particularly arteriolar tone, remains incompletely understood.
Purpose of the Study:
- To investigate the effects of NPY on hamster cheek pouch microcirculation.
- To determine NPY's impact on arteriolar diameter, leukocyte adhesion, and microvascular permeability.
- To identify the specific NPY receptor subtype involved and its interaction with adrenergic pathways.
Main Methods:
- Intravital microscopy was employed to observe the hamster cheek pouch microcirculation.
- Neuropeptide Y (NPY) was applied topically at varying concentrations (10⁻⁷ to 10⁻¹¹ M).
- Digital image analysis quantified arteriolar diameter and macromolecular extravasation; leukocyte adhesion was measured using acridine orange staining.
Main Results:
- NPY did not affect microvascular permeability or leukocyte adhesion at the tested doses.
- NPY induced a dose-dependent constriction of arterioles (10-60 µm diameter).
- The Y1-selective agonist Leu31, Pro34-NPY mimicked NPY's effect, while NPY 13-36 was inactive, indicating Y1 receptor mediation.
- Alpha-adrenergic receptor blockade did not inhibit NPY-induced vasoconstriction.
Conclusions:
- Neuropeptide Y (NPY) modulates microvascular hemodynamics primarily through arteriolar vasoconstriction.
- The hamster cheek pouch microvasculature expresses the Y1 type of NPY receptor.
- NPY-induced vasoconstriction in this model is independent of endogenous norepinephrine activity.